Skip to content

CELYAD ONCOLOGY SA

CIK 0001637890

← back to feed
Revenue (TTM)
€0
Q2 Jun 2023
Net Income (TTM)
−€40.94M
−54.4% YoY Q2 Jun 2023
EPS Diluted (TTM)
—
Q2 Jun 2023
Gross Margin
—
Q2 Jun 2023
Operating Margin
—
Q2 Jun 2023
Net Margin
—
Q2 Jun 2023
Free Cash Flow (TTM)
—
Q2 Jun 2023
Cash
€4.98M
Q2 Jun 2023
Total Debt
—
Q2 Jun 2023
Shares Outstanding
22.59M sh
Q2 Jun 2023

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings